Professionals 171 results
Capabilities 52 results
Practice Area
Government Program Fraud, False Claims Act & Qui Tam Litigation
Practice Area
Industry
Experience 8 results
Experience
|March 31, 2025
Experience
|July 15, 2024
Winston represented Montbleu Finance in the Launch of a Bond Issuance by Smallbusinessact.com
Experience
|May 10, 2024
Insights & News 1,136 results
Client Alert
|July 25, 2025
|8 Min Read
From Oversight to Omission: The OCC’s New Stance on Disparate Impact Liability
In this alert, Winston’s Financial Services Industry Group takes a closer look at the OCC’s new stance on disparate impact liability and its implications for the financial services industry.
The Office of the Comptroller of the Currency (OCC) announced on July 14, 2025, that it will cease supervising banks for disparate impact liability, instructing its examiners to “no longer examine for disparate impact.”[1] Accordingly, OCC examiners will not request, review, conclude on, or follow up on matters related to a bank’s disparate impact related risk, risk analysis, or assessment processes or procedures.[2] The OCC also removed references to disparate impact liability from its fair lending examination manual.
This policy shift follows President Trump’s April 2025 executive order mandating the elimination of disparate impact liability across federal agencies and claiming that disparate impact liability forces companies to “engage in racial balancing to avoid potentially crippling legal liability.”[3] Given the Trump administration’s approach, the OCC’s policy shift is unsurprising. But the change means financial services companies should reconsider how they evaluate and address disparate impact risk, not only from the perspective of this revised federal regulatory lens, but also with the understanding that state attorneys general and private litigants will continue to pursue disparate impact claims as long as such claims remain legally viable.
What does this mean to you and your clients?
Product Liability & Mass Torts Digest
|July 16, 2025
|7 Min Read
Delaware Supreme Court Reverses Trial Court Decision on Zantac Expert Testimony
Winston has previously analyzed several key aspects of Judge Rosenberg’s decision in the Zantac (ranitidine) MDL that excluded the plaintiffs’ experts and granted summary judgment for the defendants.
Benefits Blast
|July 14, 2025
|5 Min Read
The much-anticipated One Big Beautiful Bill Act (the OBBB) was signed into law on July 4, 2025.
Other Results 24 results
Site Content
What Is the Domestic Industry Requirement?
Site Content
What Is the Securities Act of 1933?
Location